Name (Synonyms) | Correlation |
---|
There is one clinical trial.
The COVID-19 pandemic has substantially increased the risk of adverse mental health outcomes; while physical distancing is required to reduce infection risk, it also increases loneliness and isolation and prevents access to traditional in-person therapy, which further contribute to risk of adverse mental health outcomes. These problems may be especially acute for individuals with social anxiety disorder (as many as 12% of Americans), however there is a limited evidence-base for telehealth options to directly address social anxiety. This project aims to adapt exposure therapy for social anxiety to a telehealth and physical distancing-compatible intervention, and test whether this effectively decreases loneliness in adults with elevated social anxiety.
Description: Social anxiety severity, lower scores are better (indicating less anxiety). Minimum score is 0, maximum score is 144.
Measure: Liebowitz Social Anxiety Scale (LSAS) Time: 12 weeksDescription: Therapy satisfaction subscale, higher scores are better (indicating greater satisfaction). Minimum score is 6, maximum score is 30.
Measure: Satisfaction with Therapy and Therapists Scale (STTS) Time: 12 weeksDescription: Loneliness, lower scores are better (indicating less loneliness). Minimum score is 20, maximum score is 80.
Measure: UCLA Loneliness Scale version 3 Time: 12 weeksDescription: Social anxiety severity, lower scores are better (indicating less anxiety). Minimum score is 0, maximum score is 144.
Measure: Liebowitz Social Anxiety Scale (LSAS) Time: 24 weeksDescription: Loneliness, lower scores are better (indicating less loneliness). Minimum score is 20, maximum score is 80.
Measure: UCLA Loneliness Scale version 3 Time: 24 weeks